Malaria associated anaemia, drug resistance and antimalarial combination therapy

International Journal for Parasitology

Volumn 32, Issue 13, 2002, Pages 1637-1643

  Björkman, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaemia; Combination therapy; Drug resistance; Malaria; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; ARTEMISININ; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; CHLORPROGUANIL; MEFLOQUINE; PYRIMETHAMINE; QUININE; SULFADOXINE; TETRACYCLINE;

ANEMIA; DRUG RESISTANCE; MALARIA;

ANEMIA; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFICACY; DRUG RESISTANCE; ERYTHROCYTE; HUMAN; INFECTION PREVENTION; MALARIA; PARASITE CONTROL; PARASITEMIA; PLASMODIUM FALCIPARUM;

AFRICA SOUTH OF THE SAHARA; ANEMIA; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA, FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 0037021401     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00192-3     Document Type: Conference Paper

References (47)

1. Abdalla S., Weatherall D.J., Wickramasinghe S.N., Hughes M. The anaemia of P. falciparum malaria. Br. J. Haematol. 46:1980;171-183.
2. Adjuik M., Agnamey P., Babiker A., Borrmann S., Brasseur P., Cisse M., Cobelens F., Diallo S., Faucher J.F., Garner P., Gikunda S., Kremsner P.G., Krishna S., Lell B., Loolpapit M., Matsiegui P.B., Missinou M.A., Mwanza J., Ntoumi F., Olliaro P., Osimbo P., Rezbach P., Some E., Taylor W.R. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 359:2002;1365-1372.
3. Alin M.H., Ashton M., Kihamia C.M., Mtey G.J., Bjorkman A. Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br. J. Clin. Pharmacol. 41:1996;587-592.
4. Alonso P.L., Lindsay S.W., Armstrong J.R., Conteh M., Hill A.G., David P.H., Fegan G., de Francisco A., Hall A.J., Shenton F.C., Chan K., Greenwood B.M. The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet. 337:1991;1499-1502.
5. Björkman A, 1985. Malaria epidemiology, drug protection and drug susceptibility in a holoendemic area of Liberia. MD thesis. Karolinska Institutet.
6. Bjorkman A. Interactions between chemotherapy and immunity to malaria. Prog. Allergy. 41:1988;331-356.
7. Björkman A. Drug resistance-changing patterns. Targett G.A.T., Malaria, Waiting for the Vaccine. London School of Hygiene and Tropical Medicine. First Annual Public Health Forum. 1991;105-120 Wiley, New York, NY.
8. Bjorkman A., Phillips-Howard P.A. The epidemiology of drug-resistant malaria. Trans. R. Soc. Trop. Med. Hyg. 84:1990;177-180.
9. Bjorkman A., Brohult J., Pehrson P.O., Willcox M., Rombo L., Hedman P., Kollie E., Alestig K., Hanson A., Bengtsson E. Monthly antimalarial chemotherapy to children in a holoendemic area of Liberia. Ann. Trop. Med. Parasitol. 80:1986;155-167.
10. Bloland P.B., Lackritz E.M., Kazembe P.N., Were J.B., Steketee R., Campbell C.C. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J. Infect. Dis. 167:1993;932-937.
11. Bwijo B., Alin M.H., Abbas N., Wernsdorfer W., Bjorkman A. Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics. Trop. Med. Int. Health. 2:1997;461-467.
12. Chawira A.N., Warhurst D.C. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. J. Trop. Med. Hyg. 90:1987;1-8.
13. Chawira A.N., Warhurst D.C., Robinson B.L., Peters W. The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. 81:1987;554-558.
14. Ekvall H., Premji Z., Bjorkman A. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans. R. Soc. Trop. Med. Hyg. 92:1998;556-560.
15. Ekvall H., Arese P., Turrini F., Ayi K., Mannu F., Premji Z., Bjorkman A. Acute haemolysis in childhood falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 95:2001;611-617.
16. Ekvall H., Premji Z., Bennett S., Bjorkman A. Hemoglobin concentration in children in a malaria holoendemic area is determined by cumulated Plasmodium falciparum parasite densities. Am. J. Trop. Med. Hyg. 64:2001;58-66.
17. Ekvall, H., 2000. Plasmodium falciparum malaria and anaemia in childhood. MD thesis. Karolinska Institutet ISBN 91-628-4279-10
18. Farnert A., Rooth I., Svensson, Snounou G., Bjorkman A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J. Infect. Dis. 179:1999;989-995.
19. Färnert A., Tenstam K., Lebbad M., Tegerström J., Berrgren-Palme I., Bronner U., Swedberg G., Björkman A. Diversity and dynamics of Plasmodium Falciparum infections travellers and the influence of prophylaxis. Am. J. Trop. Med. Hyg. 2002;. (in press).
20. Fivelman Q.L., Walden J.C., Smith P.J., Folb P.I., Barnes K.I. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 93:1999;429-432.
21. Fleming A.F., Werblinska B. Anaemia in childhood in the guinea savanna of Nigeria. Ann. Trop. Paediatr. 2:1982;161-173.
22. Greenwood B.M. The epidemiology of malaria. Ann. Trop. Med. Parasitol. 91:1997;763-769.
23. Gupta S., Thapar M.M., Mariga S.T., Wernsdorfer W.H., Bjorkman A. Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Exp. Parasitol. 100:2002;28-35.
24. Gupta S., Thapar M.M., Wernsdorfer W.H., Bjorkman A. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 46:2002;1510-1515.
25. Hassan Alin M., Bjorkman A., Wernsdorfer W.H. Synergism of benflumetol and artemether in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61:1999;439-445.
26. ter Kuile F.O., Nosten F., Luxemburger C., Kyle D., Teja-Isavatharm P., Phaipun L., Price R., Chongsuphajaisiddhi T., White N.J. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull. World Health Organ. 73:1995;631-642.
27. Marsh K. Malaria disaster in Africa. Lancet. 352:1998;924.
28. McGregor I.A. The significance of parasitic infections in terms of clinical disease: a personal view. Parasitology. 94:1987;S159-S178.
29. McGregor I.A., Gilles H.M., Walters J.J., Davies A.H., Pearson F.A. Effects of heavy and repeated malaria infections in Gambian infants and children: effects of erythrocytic parasitization. Br. Med. J. ii:1956;686-692.
30. McIntosh H.M., Greenwood B.M. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria-a systematic review. Ann. Trop. Med. Parasitol. 92:1998;265-270.
31. Menendez C., Kahigwa E., Hirt R., Vounatsou P., Aponte J.J., Font F., Acosta C.J., Schellenberg D.M., Galindo C.M., Kimario J., Urassa H., Brabin B., Smith T.A., Kitua A.Y., Tanner M., Alonso P.L. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet. 350:1997;844-850.
32. Nosten F., van Vugt M., Price R., Luxemburger C., Thway K.L., Brockman A., McGready R., ter Kuile F., Looareesuwan S., White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 356:2000;297-302.
33. Schellenberg D., Menendez C., Kahigwa E., Aponte J., Vidal J., Tanner M., Mshinda H., Alonso P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet. 357:2001;1471-1477.
34. von Seidlein L., Milligan P., Pinder M., Bojang K., Anyalebechi C., Gosling R., Coleman R., Ude J.I., Sadiq A., Duraisingh M., Warhurst D., Alloueche A., Targett G., McAdam K., Greenwood B., Walraven G., Olliaro P., Doherty T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 355:2000;352-357.
35. Snow R.W., Bastos de Azevedo I., Lowe B.S., Kabiru E.W., Nevill C.G., Mwankusye S., Kassiga G., Marsh K., Teuscher T. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop. 57:1994;289-300.
36. Snow R.W., Craig M.H., Deichmann U., le Sueur D. A preliminary continental risk map for malaria mortality among African children. Parasitol. Today. 15:1999;99-104.
37. Snow R.W., Trape J.F., Marsh K. The past, present and future of childhood malaria mortality in Africa. Trends Parasitol. 17:2001;593-597.
38. Thaithong S. Variability in drug susceptibility amongst clones and isolates of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 82:1998;33-36.
39. Verhoeff F.H., Brabin B.J., Masache P., Kachale B., Kazembe P., Van der Kaay H.J. Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. Ann. Trop. Med. Parasitol. 91:1997;133-140.
40. Warsame M., Wernsdorfer W.H., Huldt G., Bjorkman A. An epidemic of Plasmodium falciparum malaria in Balcad, Somalia, and its causation. Trans. R. Soc. Trop. Med. Hyg. 89:1995;142-145.
41. Weatherall D.J., Abdalla S. The anaemia of Plasmodium falciparum malaria. Br. Med. Bull. 38:1982;147-151.
42. Weber M.W., Kellingray S.D., Palmer A., Jaffar S., Mulholland E.K., Greenwood B.M. Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull. World Health Organ. 75:1997;113-118.
43. White N.J. Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30:1992;571-585.
44. White N.J. Preventing antimalarial drug resistance through combinations. Drug Resist. Update. 1:1998;3-9.
45. WHO . Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. 1996;World Health Organization, Geneva. (mimeographed document WHO/MAL/96.1077).
46. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:2002;209-218.
47. Zucker J.R., Perkins B.A., Jafari H., Otieno J., Obonyo C., Campbell C.C. Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull. World Health Organ. 75:1997;97-102.